Edinburgh Research Explorer

Experimental validation of the hyperpolarized (129) Xe chemical shift saturation recovery technique in healthy volunteers and subjects with interstitial lung disease

Research output: Contribution to journalArticlepeer-review

  • Neil J Stewart
  • General Leung
  • Graham Norquay
  • Helen Marshall
  • Juan Parra-Robles
  • Philip S Murphy
  • Rolf F Schulte
  • Charlie Elliot
  • Robin Condliffe
  • Paul D Griffiths
  • David G Kiely
  • Moira K Whyte
  • Jan Wolber
  • Jim M Wild

Related Edinburgh Organisations

Original languageEnglish
JournalMagnetic Resonance in Medicine
Publication statusPublished - 8 Aug 2014


PURPOSE: To assess the sensitivity of the hyperpolarized (129) Xe chemical shift saturation recovery (CSSR) technique for noninvasive quantification of changes to lung microstructure and function in idiopathic pulmonary fibrosis (IPF) and systemic sclerosis (SSc).

METHODS: Ten healthy volunteers, four subjects with SSc and four with IPF were scanned at 1.5 T. A CSSR pulse sequence was implemented using binomial-composite radiofrequency pulses to monitor (129) Xe magnetization in tissues and blood plasma (T/P) and red blood cells (RBCs). The dynamics of (129) Xe uptake into these compartments were fitted with three existing analytical models of gas diffusion to extract parameters of lung physiology. These parameters were quantitatively compared between models.

RESULTS: Uptake of xenon into the pulmonary capillaries was impaired in subjects with IPF and SSc. Statistically significant septal thickening was measured by (129) Xe CSSR in IPF patients. Preliminary data suggests age-dependent alterations to septal thickness in healthy volunteers. These findings were reproduced using each of the literature models. CSSR-derived parameters were compared with gold-standard indicators of pulmonary function; diffusing capacity of carbon monoxide and pulmonary transit-time.

CONCLUSIONS: CSSR with hyperpolarized (129) Xe is sensitive to pathology-induced degradation of lung structure/function and shows promise for quantification of disease severity and monitoring treatment response. Magn Reson Med, 2014. © 2014 Wiley Periodicals, Inc.

ID: 17207994